Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00014688
DRKS00014688
Not yet recruiting
Phase 4

Evaluation of Biomarkers for the Assessment of Disease Activity of Eosinophilic Esophagitis (EoE) in Children - Pediatic EOE Biomarkers

Abteilung für Gastroenterologie und HepatologieKinderklinik Erlangen0 sites100 target enrollmentJuly 12, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsK20K21T78.1OesophagitisGastro-oesophageal reflux diseaseOther adverse food reactions, not elsewhere classified

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
K20
Sponsor
Abteilung für Gastroenterologie und HepatologieKinderklinik Erlangen
Enrollment
100
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 12, 2018
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Abteilung für Gastroenterologie und HepatologieKinderklinik Erlangen

Eligibility Criteria

Inclusion Criteria

  • •Pediatric patients including 18 years of age with clinical or laboratorial suspicion of eosinophilic esophagitis

Exclusion Criteria

  • •\- Other causes for esophageal eosinophilia like chronic inflammatory bowel disease or celiac diesase
  • •\- Esophageal candidosis or infection with Herpes simplex
  • •\- Present esophageal gastritis or esophageal Enteritis
  • •\- Ongoing Treatment with immunosuppressive or immunomodulating substances

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Phyisician Led CIMAvax-EGF lung biomarkersAdvanced non small cell lung cancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract Diseases
RPCEC00000355Center of Molecular Immunology (CIM)140
Not yet recruiting
Not Applicable
CIMAvax-EGF/Lung cancer/Biomarkers/Prospective CTAdvanced non small cell lung cancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract Diseases
RPCEC00000392Center of Molecular Immunology130
Not yet recruiting
Not Applicable
CIMAvaxEGF in Non Small Cell Lung Cancer. Exploratory Study of Biomarkerson-Small Cell Lung Cancer (NSCLC)
RPCEC00000445Center of Molecular Immunology (CIM)20
Not yet recruiting
Not Applicable
Evaluation study of biological markers involved in cardiovascular diseases in childhoodcardiovascular diseases
JPRN-UMIN000002281Kyoto university100
Recruiting
Not Applicable
Identification and analysis of biomarkers for the course of demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosisDemyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosis
DRKS00031139MPI-NAT1,000